The objective of this study was to examine if (R)-methanandamide, a metabol
ically stable chiral analog of the endogenous ligand anandamide, is a canna
bimimetic with a lower efficacy than Delta(9)-THC. Employing a two-lever ch
oice drug discrimination procedure, rats were trained to discriminate betwe
en 1.8, 3.0, or 5.6 mg/kg Delta(9)-tetrahydrocannabinol (Delta(9)-THC) and
vehicle. Different training doses were used in order to create assays with
different efficacy demands. Generalization tests with 18 mg/kg (R)-methanan
damide yielded around 90% Delta(9)-THC responses in the two lower Delta(9)-
THC training dose conditions. However, only around 60% Delta(9)-THC respons
es occurred in the 5.6 mg/kg Delta(9)-THC training dose condition in tests
with 18 mg/kg (R)-methanandamide; a higher dose (30 mg/kg) produced even fe
wer Delta(9)-THC-appropriate responses in this group. Morphine did not subs
titute for Delta(9)-THC. In conclusion, the data with Delta(9)-THC and (R)-
methanandamide indicate that cannabinoid agonists can have varying degrees
of intrinsic activity at a receptor site, or may produce their behavioral a
ctions through multiple mechanisms, or both.